Leelapatana, P.; Thongprayoon, C.; Prasitlumkum, N.; Vallabhajosyula, S.; Cheungpasitporn, W.; Chokesuwattanaskul, R.
Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials. Diseases 2021, 9, 31.
https://doi.org/10.3390/diseases9020031
AMA Style
Leelapatana P, Thongprayoon C, Prasitlumkum N, Vallabhajosyula S, Cheungpasitporn W, Chokesuwattanaskul R.
Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials. Diseases. 2021; 9(2):31.
https://doi.org/10.3390/diseases9020031
Chicago/Turabian Style
Leelapatana, Pattranee, Charat Thongprayoon, Narut Prasitlumkum, Saraschandra Vallabhajosyula, Wisit Cheungpasitporn, and Ronpichai Chokesuwattanaskul.
2021. "Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials" Diseases 9, no. 2: 31.
https://doi.org/10.3390/diseases9020031
APA Style
Leelapatana, P., Thongprayoon, C., Prasitlumkum, N., Vallabhajosyula, S., Cheungpasitporn, W., & Chokesuwattanaskul, R.
(2021). Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials. Diseases, 9(2), 31.
https://doi.org/10.3390/diseases9020031
